TY - JOUR
T1 - Prone versus supine position for adjuvant breast radiotherapy
T2 - A prospective study in patients with pendulous breasts
AU - Krengli, Marco
AU - Masini, Laura
AU - Caltavuturo, Tina
AU - Pisani, Carla
AU - Apicella, Giuseppina
AU - Negri, Eleonora
AU - Deantonio, Letizia
AU - Brambilla, Marco
AU - Gambaro, Giuseppina
N1 - Funding Information:
The project received grants from the Piedmont Region in the frame of “Ricerca Sanitaria Finalizzata” and from the “Lega Italiana per la lotta contro i tumori-Sezione Provinciale di Novara ONLUS”. We thank Drs. Irene Manfredda, Debora Beldì, Cesare Bolchini, and Chiara Cicconi for the support in the realization of the project.
PY - 2013/10/8
Y1 - 2013/10/8
N2 - Purpose: To analyze dosimetric parameters of patients receiving adjuvant breast radiotherapy (RT) in the prone versus supine position.Methods and materials: Forty-one out of 55 patients with pendulous breasts and candidates for adjuvant RT were enrolled in the study after informed consent. They underwent computed tomography (CT)-simulation in both prone and supine position. Target and non target volumes were outlined on CT images. Prescribed dose was 50 Gy delivered by two tangential photon fields followed by 10 Gy electron boost. Target coverage and dose homogeneity to clinical target volume (CTV) and planning target volume (PTV) were assessed by V95, V105 and V107 and dose to lung, heart and left anterior descending coronary artery (LAD) by V5, V10, V20, and mean and maximum dose. Data were analyzed by Student's t-test.Results: CTV and PTV coverage was significantly better in supine than in prone position. Lung V5, V10, and V20 were significantly lower in prone than in supine position. Heart V5, V10, V20, and LAD mean and maximum dose, in the 17 patients with left breast tumor, were lower in prone than in supine position, but without statistical significance. Based on treatment planning data and on treatment feasibility, 29/41 patients (70.7%) were treated in prone position. Acute and late toxicities of patients treated in prone and in supine position were not statistically different.Conclusion: Prone position is a favorable alternative for irradiation of mammary gland in patients with pendulous breasts and in our series was adopted in 71% of the cases.
AB - Purpose: To analyze dosimetric parameters of patients receiving adjuvant breast radiotherapy (RT) in the prone versus supine position.Methods and materials: Forty-one out of 55 patients with pendulous breasts and candidates for adjuvant RT were enrolled in the study after informed consent. They underwent computed tomography (CT)-simulation in both prone and supine position. Target and non target volumes were outlined on CT images. Prescribed dose was 50 Gy delivered by two tangential photon fields followed by 10 Gy electron boost. Target coverage and dose homogeneity to clinical target volume (CTV) and planning target volume (PTV) were assessed by V95, V105 and V107 and dose to lung, heart and left anterior descending coronary artery (LAD) by V5, V10, V20, and mean and maximum dose. Data were analyzed by Student's t-test.Results: CTV and PTV coverage was significantly better in supine than in prone position. Lung V5, V10, and V20 were significantly lower in prone than in supine position. Heart V5, V10, V20, and LAD mean and maximum dose, in the 17 patients with left breast tumor, were lower in prone than in supine position, but without statistical significance. Based on treatment planning data and on treatment feasibility, 29/41 patients (70.7%) were treated in prone position. Acute and late toxicities of patients treated in prone and in supine position were not statistically different.Conclusion: Prone position is a favorable alternative for irradiation of mammary gland in patients with pendulous breasts and in our series was adopted in 71% of the cases.
KW - Breast cancer
KW - Dosimetric analysis
KW - Prone setup
UR - http://www.scopus.com/inward/record.url?scp=84885007153&partnerID=8YFLogxK
U2 - 10.1186/1748-717X-8-232
DO - 10.1186/1748-717X-8-232
M3 - Article
SN - 1748-717X
VL - 8
JO - Radiation Oncology
JF - Radiation Oncology
IS - 1
M1 - 232
ER -